New orders totalled €146.9 million compared to restated €119.7 million for the first three months of 2013; the order backlog amounted to €5,446.3 million (restated €5,567.3 million at 31 December 2013, restated €5,537.8 million at 31 March 2013 ).
Revenue came to €263.1 million, up by €15.3 million on the restated €247.9 million of the first quarter of 2013.
The increase is mainly due to a different mix as a result of commencement of the new contracts acquired in recent years.
Operating profit (EBIT) came to €21.6 million, compared to restated €20.4 million for the corresponding period of the previous year. The €1.2 million increase is due to larger volumes. ROS was 8.2%, in line with the first quarter of 2013 (restated).
The profit for the period came to €14.0 million (€12.1 million for the corresponding period of 2013).
The group’s net financial position decreased from restated €245.5 million at 31 December 2013 to €214.7 million.
Research and development expense recognised in profit or loss amounted to €6.2 million, down from the €7.3 million expense recognised in the corresponding period of the previous year.
The group’s headcount decreased by a net 26 employees to 3,916 from restated 3,942 at 31 March 2013 andrestated 3,929 at 31 December 2013.
The average headcount of 3,884 employees is in line with the restated 2013 figures (3,882 for the first quarter of 2013 and 3,899 for 2013).